tirzepatide decision FDA Says Compounded Must Exit the Market court ruling on tirzepatide decision

Harlan Krunholz, MD wrote previously for Forbes about how a Cochrane review of studies on the efficacy and safety of Tamiflu found that "the manufacturer of the drug sponsored all the trials and the reviewers found evidence of publication and reporting biases." He added that "With so much at stake I was surprised that there had been no prospective, placebo-controlled trials conducted that were funded by an independent source." Looks like more independent scientific studies may be necessary before making more definitive conclusions about the safety of Tamiflu

Reconstituted semaglutide expires after 28 days in the refrigerator

That makes sense, but you do not need a very dark tan to handle vitamin D status

Neuroprotective Effects Studied for potential neuroprotective properties

As research expands, understanding how gastric physiology adapts to GLP-1 therapy will remain important for optimizing therapeutic strategies

These pros can help you build a meal plan that keeps your strands strong and your health goals in mind